Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rat

Toxicol Sci. 1999 Oct;51(2):202-10. doi: 10.1093/toxsci/51.2.202.

Abstract

The effects of the synthetic phenolic antioxidants (butylated hydroxyanisole and butylated hydroxytoluene) on the in vivo acetylation of 2-aminofluorene and formation of DNA-2-aminofluorene adducts were investigated in male Sprague-Dawley rats. For in vitro examination, cytosols and intact cells, with or without butylated hydroxyanisole and butylated hydroxytoluene co-treatment, showed different percentages of 2-aminofluorene acetylation and DNA-2-aminofluorene adducts. For in vivo examination, pre-treatment of male rats with butylated hydroxyanisole and butylated hydroxytoluene (10 mg/kg) 48 h prior to the administration of 2-aminofluorene (50 mg/kg) resulted in 34% and 18%, 29% and 20% decreases, respectively, in the urinary and fecal recovery of N-acetyl-2-aminofluorene, and 34% and 19% decreases, respectively, in the metabolic clearance of 2-aminofluorene to N-acetyl-2-aminofluorene. Following exposure of rats to the 2-aminofluorene, with or without pretreatment with butylated hydroxyanisole and butylated hydroxytoluene, DNA-2-aminofluorene adducts were observed in the target tissues of liver and bladder, and also in circulating leukocytes. The DNA-2-aminofluorene adducts in liver, bladder, and leukocytes were decreased by pretreatment with butylated hydroxyanisole and butylated hydroxytoluene. This is the first demonstration that synthetic phenolic antioxidants decrease the N-acetylation of carcinogens and formation of DNA-carcinogen adducts in vivo.

MeSH terms

  • Acetylation / drug effects
  • Animals
  • Antioxidants / pharmacology*
  • Arylamine N-Acetyltransferase / blood
  • Arylamine N-Acetyltransferase / metabolism
  • Butylated Hydroxyanisole / pharmacology*
  • Butylated Hydroxytoluene / pharmacology*
  • Carcinogens / metabolism*
  • Carcinogens / pharmacokinetics
  • Carcinogens / toxicity
  • DNA Adducts / metabolism*
  • Dose-Response Relationship, Drug
  • Fluorenes / metabolism*
  • Fluorenes / pharmacokinetics
  • Fluorenes / toxicity
  • Kinetics
  • Liver / enzymology
  • Lung / enzymology
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Urinary Bladder / enzymology

Substances

  • 2-aminofluorene-DNA complex
  • Antioxidants
  • Carcinogens
  • DNA Adducts
  • Fluorenes
  • Butylated Hydroxytoluene
  • Butylated Hydroxyanisole
  • 2-aminofluorene
  • Arylamine N-Acetyltransferase